Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer
Release Date:
Andrea Apolo describes the results of this positive trial.
Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer
Andrea Apolo describes the results of this positive trial.
Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer